Insider Transactions in Q2 2024 at Selecta Biosciences Inc (SELB)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 08
2024
|
Michael Singer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
643,630
+49.57%
|
-
|
|
Apr 08
2024
|
Michael Singer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
110,151
+47.91%
|
-
|
|
Apr 08
2024
|
Timothy A Springer Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
826,169
+30.0%
|
-
|
|
Apr 08
2024
|
Timothy A Springer Director |
SELL
Exercise of conversion of derivative security
|
Indirect |
24,785
-100.0%
|
-
|
|
Apr 08
2024
|
Timothy A Springer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,130,846
+48.54%
|
-
|
|
Apr 08
2024
|
Timothy A Springer Director |
SELL
Exercise of conversion of derivative security
|
Direct |
123,925
-100.0%
|
-
|
|
Apr 08
2024
|
Murat Kalayoglu Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,926,764
+49.08%
|
-
|
|
Apr 08
2024
|
Murat Kalayoglu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
491,853
+49.27%
|
-
|
|
Apr 08
2024
|
Elizabeth Hoge > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,418,617
+49.17%
|
-
|